Hormones as the next frontier of women’s longevity and healthspan
Women spend 25% more of their lives in poor health than men, yet female-specific conditions receive just 1% of non-oncology research. This talk explores how continuous, non-invasive hormone monitoring turns an overlooked blind spot into actionable data, opening a new market for personalised and accessible healthcare and laying the groundwork for world models of human health. Clair Health’s 22-year-old founder shares how she built the scientific rigour and consumer trust needed to raise an $11.6M seed round for the first non-invasive continuous hormone-monitoring wearable and the opportunity ahead.
Featuring
Jenny Duan Speaker
Co-Founder & CEO at Clair Health
Attendees